Rating Change: H.C. Wainwright: Time To Buy Cara Therapeutics (NASDAQ:CARA)? Has $20 Valuation Target - Thorold News

Thorold News
Rating Change: H.C. Wainwright: Time To Buy Cara Therapeutics (NASDAQ:CARA)? Has $20 Valuation Target
Thorold News
Expert analysts at H.C. Wainwright has begun coverage on shares of Cara Therapeutics (NASDAQ:CARA) in a a report published on Thursday, 13 October. The financial company set a “Buy” rating on the stock. H.C. Wainwright's TP of $20 suggests potential ...
Cara Therapeutics Inc. (CARA) Receives New Coverage from ...BBNS
Cara Therapeutics Inc (CARA) is Ini